Thoracoscopic Segmentectomy Within an Enhanced Recovery Pathway Improves Days Alive and Out of Hospital Compared with Lobectomy
Interdisciplinary CardioVascular and Thoracic Surgery · 2026
DOI: 10.1093/icvts/ivag043 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, 2026. Verfasst von Lin Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark. Hauptthemen laut MEDLINE: Lung Neoplasms, Pneumonectomy, Carcinoma, Non-Small-Cell Lung, Thoracic Surgery, Video-Assisted. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
This study aims to investigate the first 90 days alive and out of hospital (DAOH90) following enhanced recovery thoracoscopic segmentectomy versus lobectomy.
Methods
A retrospective analysis for consecutive thoracoscopic segmentectomies and lobectomies for clinical stage IA1-2 non-small cell lung cancer (cIA1-2 NSCLC) was performed between January 2018 and March 2024. All factors contributing to reduced DAOH90 were analyzed individually. The association between surgical extent and DAOH90 was assessed using a multivariable logistic regression model. Sensitivity analyses were performed after propensity score matching.
Results
Of 720 patients, 591 underwent lobectomy and 129 underwent segmentectomy. Compared with lobectomy, patients undergoing segmentectomy had poorer lung function and exercise capacity, more comorbidities, slightly longer operative duration, and less blood loss. The median DAOH90 was 1 day longer after segmentectomy than lobectomy (87 vs 86 days, P = .049). Air leak > 1 day (38.3% vs 40.0%), pneumonia (13.3% vs 18.3%), and pain (13.3% vs 23.3%) were important reasons to reduce DAOH90, all occurring more frequently in the lobectomy group. Social factors (37.5% vs 25.8%) were also a predominant cause in both groups, particularly after segmentectomy. Other causes were less common. In multivariable analysis, lobectomy (vs segmentectomy, OR 1.44, P = .048) was identified as an independent predictor of shorter DAOH90, along with body mass index, lung function, and cardiac comorbidity. The results of the sensitivity analysis were consistent with these findings.
Conclusions
Following an enhanced recovery thoracoscopic protocol, segmentectomy for well-selected patients with cIA1-2 NSCLC may result in longer DAOH and less postoperative complications compared to lobectomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark.
- Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
- Section for Surgical Pathophysiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark.
ORCID-Profile: Lin Huang, Henrik Kehlet, René Horsleben Petersen
Zitieren
APA
Huang, L., Kehlet, H., & Petersen, R. H. (2026). Thoracoscopic Segmentectomy Within an Enhanced Recovery Pathway Improves Days Alive and Out of Hospital Compared with Lobectomy. Interdisciplinary CardioVascular and Thoracic Surgery. https://doi.org/10.1093/icvts/ivag043
Vancouver
Huang L, Kehlet H, Petersen RH. Thoracoscopic Segmentectomy Within an Enhanced Recovery Pathway Improves Days Alive and Out of Hospital Compared with Lobectomy. Interdisciplinary CardioVascular and Thoracic Surgery. 2026. doi:10.1093/icvts/ivag043
BibTeX
@article{Huang2026,
author = {Huang, Lin and Kehlet, Henrik and Petersen, René Horsleben},
title = {Thoracoscopic Segmentectomy Within an Enhanced Recovery Pathway Improves Days Alive and Out of Hospital Compared with Lobectomy},
journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
year = {2026},
doi = {10.1093/icvts/ivag043}
}
EUVIMED